Patrick Frost, PhD

Patrick Frost, PhD

Jan 15, 2016

Group 6 Copy 49
2
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Round Goby assault on American rivers: How fast, how far, how complete?

After conquering the Great Lakes, what will the invasive Round Goby do to fish in our streams? Four years...

A Bird's-eye View of Frog Habitats: Using a Drone to Survey Wetlands

I study vulnerable frog species that inhabit human-constructed wetlands in the Grand River Grasslands of...

Short-Term Innovative Research (STIR): Predoctoral Grant Competition

Writing grants is the number one skill required for a successful independent scientist. This project provides...

Backer Badge Funded